Tecan appoints Ulrich Kanter to the Management Board

Tecan Group AG / Tecan appoints Ulrich Kanter to the Management Board . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Männedorf, Switzerland, June 11, 2014 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that Ulrich Kanter has been appointed a member of the Management Board. As Head of the Development & Operations division, effective July 14, 2014, he will assume responsibility for development activities, production, supply chain management and materials purchasing at Tecan. Dr. Martin Brusdeilins, who has headed this division since November 2011, will retire at the end of September 2014 and step down from the Management Board. Until this time, he will continue to act as Chief Scientific Officer, a position that he holds in addition to being Head of the division. Tecan has initiated the search for a successor to take on this role.

Tecan CEO Dr. David Martyr commented: "I am very pleased that Ulrich Kanter will be strengthening the Tecan management team with his extensive experience in a variety of management positions in the diagnostic and life science industry. Tecan has great potential to considerably reduce product manufacturing costs through improvements in the supply chain, in materials purchasing and - in the medium term - throughout the development process. We have set this as a company-wide priority for 2014 and have launched a multiyear project. Ulrich Kanter brings with him a huge wealth of experience in implementing these types of projects and has a record of formidable successes.

I would like to thank Martin Brusdeilins personally and also on behalf of the entire management team and the Board of Directors for his valuable contribution to the development of Tecan. We wish him all the best for his retirement."

Ulrich Kanter worked in various areas and held diverse positions with increasing management responsibility at Roche Diagnostics from 2000. He was General Manager and Head of Research & Development in Graz, Austria, from 2007, with responsibility for the entire value chain of blood gas and electrolyte analysis systems for this Roche division. Prior to this, he managed the development of these systems as Senior Vice President Research & Development, and as Site Manager was responsible for management of the supply chain as well as all administrative matters at the Graz site.